Recent clinical research highlights new risk factors for chronic conditions while regulators investigate the safety of common injectable treatments.

A survey reveals that emergency department staff frequently encounter workplace violence, with many personnel lacking confidence that reporting incidents results in meaningful administrative action.

New research suggests that endometriosis subtypes are linked to distinct clinical profiles, including specific pain conditions, immune disorders, and menstrual histories.

A study indicates that current e-cigarette users have a significantly higher risk of developing autoimmune diseases, specifically rheumatoid arthritis and systemic lupus erythematosus.

Clinical findings show that approximately one in five patients with Pseudomonas aeruginosa bloodstream infections exhibit skin involvement, particularly those who are neutropenic.

A comparative analysis of inflammatory bowel disease treatments demonstrates that the risk for cancer remains low and consistent across major advanced therapy classes.

The European Medicines Agency has initiated a safety review of injectable iron medications due to potential risks of severe hypophosphatemia and osteomalacia.

GLP-1 receptor agonists have been shown to provide metabolic benefits for rheumatology patients, contributing to sustained weight loss and reduced systemic inflammation.

Patients diagnosed with mismatch repair-deficient oesophagogastric adenocarcinoma demonstrate improved survival outcomes when treated with perioperative chemotherapy.